Búsqueda - Portal Conocimiento Público CL

Artículo 2014

Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

Autor: Cabrera, D. Gutiérrez, J. Cabello-Verrugio, C. Morales, M. G. Mezzano, S. Fadic, R. Casar, J. C. Hancke, J. L. Brandan, E.

Background: Duchenne muscular dystrophy (DMD) is characterized by the absence of the cytoskeletal protein dystrophin, muscle wasting, increased transforming growth factor type beta (TGF-β) signaling, and fibrosis. At the present time, the only clinically validated treatments for DMD are glucocort...

Enlace original: https://repositorio.uc.cl/handle/11534/27461 https://repositorio.uc.cl/handle/11534/27461

Repositorio UC

Andrographolide

Cell therapy

DMD

Listar archivos Citar Enlace permanente

Cabrera, D. , Gutiérrez, J. , Cabello-Verrugio, C. , Morales, M. G. , Mezzano, S. , Fadic, R. , Casar, J. C. , Hancke, J. L. , Brandan, E. , [Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis] , Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Modelo determinístico para la planificación táctica y operativa de sistemas de cosecha

Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Modelo determinístico para la planificación táctica y operativa de sistemas de cosecha

Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

[Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis.pdf]